early-stage life sciences companies.
The Accelerator program seeks to
support and “de-risk” early-stage
companies by providing working
capital. We’ve had more than 200
companies apply for Accelerator
funding, demonstrating the demand
for this sort of program in the
marketplace.
The twenty companies selected
for funding cover the full range of
life sciences in our state, from
biotech to pharmaceuticals, medical
devices and diagnostics. These
companies are engaged in the
process of bringing innovation to
the marketplace – and were funded
by the Center because they are
turning good science into good
business opportunities.
Visit us online at
MLSC
Massachusetts Li
